Application Sponsors
| ANDA 211592 | INVAGEN PHARMS |  | 
Marketing Status
Application Products
| 001 | FOR SOLUTION;ORAL | 500MG/PACKET | 0 | VIGABATRIN | VIGABATRIN | 
FDA Submissions
| UNKNOWN;  | ORIG | 1 | AP | 2019-12-03 | STANDARD  | 
| REMS; REMS | SUPPL | 2 | AP | 2020-04-17 |   | 
| LABELING; Labeling | SUPPL | 3 | AP | 2022-10-28 | STANDARD  | 
| REMS; REMS | SUPPL | 4 | AP | 2020-10-02 |   | 
| LABELING; Labeling | SUPPL | 5 | AP | 2022-10-28 | STANDARD  | 
| REMS; REMS | SUPPL | 6 | AP | 2022-10-12 |   | 
Submissions Property Types
| ORIG | 1 | Null | 7 | 
| SUPPL | 2 | Null | 7 | 
| SUPPL | 3 | Null | 7 | 
| SUPPL | 4 | Null | 7 | 
| SUPPL | 5 | Null | 15 | 
| SUPPL | 6 | Null | 15 | 
TE Codes
CDER Filings
INVAGEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211592
            [companyName] => INVAGEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"VIGABATRIN","activeIngredients":"VIGABATRIN","strength":"500MG\/PACKET","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/03\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"10\/02\/2020","submission":"SUPPL-4","supplementCategories":"REMS - MODIFIED - D-N-A","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"04\/17\/2020","submission":"SUPPL-2","supplementCategories":"REMS - MODIFIED - D-N-A","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-10-02
        )
)